FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Dilip Davda has given "May Apply" recommendation to Par Drugs IPO.
Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
---|---|---|---|---|---|
Count | 0 | 1 | 0 | 0 | 0 |
% | 0.00 | 100.00 | 0.00 | 0.00 | 0.00 |
Reviewer | Recommendation | Past Reviews |
---|---|---|
Dilip Davda | May Apply |
[Dilip Davda] Investors may consider investment for the long term. Based on financial parameters (including P/BV data) issue appears reasonably priced. Promoters have converted shares at Rs. 66 while the issue is priced lower. Employees too are offered shares at the same price of IPO. Read detail review...
Post Recommendation Manage Recommendations
Note:
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|